Elevance Health Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -213.7% | – | -77.4% | +498.9% | -73.6% | +44.1% | +102.0% | -44.7% | -92.6% | +5,057.1% | -55.8% | – | |
| – | -0.5% | -21.9% | +1.2% | -1.8% | +21.0% | -6.3% | +1.9% | +1.8% | +4.9% | -12.8% | +3.4% | – | |
| – | -7.7% | -13.9% | +48.4% | -28.3% | -143.9% | – | +0.0% | +3.7% | -64.3% | +83.3% | +36.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2,174.3% | – | – | – | -101.4% | – | – | – | – | – | -96.4% | – | |
| – | +2.2% | -14.4% | +15.8% | +2.8% | -3.0% | -39.1% | +36.2% | +34.8% | -18.6% | -19.8% | +22.1% | – | |
| – | -77.3% | +124.5% | -64.6% | -51.0% | +308.5% | – | -767.0% | +78.2% | – | -453.9% | – | – | |
| – | -0.6% | +9.5% | -0.3% | +0.0% | -1.3% | +3.5% | -0.3% | -1.0% | -1.0% | -0.3% | -0.8% | – | |
| – | +93.3% | -39.0% | -18.2% | -87.0% | +2,918.3% | -51.4% | -57.0% | +131.7% | -46.2% | +138.6% | -79.2% | – | |
| – | – | – | – | – | – | -121.4% | – | +597.4% | +17.0% | -183.5% | -43.3% | – | |
| – | -60.4% | – | +1,987.5% | -237.0% | – | -235.6% | -83.9% | – | -2.9% | -1,165.7% | -40.6% | – | |
| – | -573.4% | – | – | +405.2% | -69.2% | -286.7% | – | -85.6% | +408.5% | -78.7% | +246.4% | – | |
| – | -243.7% | – | -92.7% | +1,791.1% | -83.6% | +113.8% | +117.7% | -56.6% | -127.0% | – | -60.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.